Norway Drug Device Combination Products Market Size & Outlook
Norway drug device combination products market, 2018-2030 (US$M)
Related Markets
Norway drug device combination products market highlights
- The Norway drug device combination products market generated a revenue of USD 2,020.5 million in 2023 and is expected to reach USD 3,533.4 million by 2030.
- The Norway market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
- In terms of segment, transdermal patches was the largest revenue generating product in 2023.
- Drug Eluting Stents is the most lucrative product segment registering the fastest growth during the forecast period.
Drug device combination products market data book summary
| Market revenue in 2023 | USD 2,020.5 million |
| Market revenue in 2030 | USD 3,533.4 million |
| Growth rate | 8.3% (CAGR from 2023 to 2030) |
| Largest segment | Transdermal patches |
| Fastest growing segment | Drug Eluting Stents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
| Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
Other key industry trends
- In terms of revenue, Norway accounted for 1.5% of the global drug device combination products market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK drug device combination products market is projected to lead the regional market in terms of revenue in 2030.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 6,320.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Device Combination Products Market Scope
Drug Device Combination Products Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway drug device combination products market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 22.94% in 2023. Horizon Databook has segmented the Norway drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Norway’s healthcare infrastructure for drug-device combination products is well-developed and patientcentered, with a strong focus on quality, safety, & innovation. There are significant opportunities for the U.S.-based companies that have innovative products related to several medical devices, such as ablation devices and others.
There is a strong opportunity for several new entrants to enter and establish their presence in Norway. Furthermore, all hospitals in Norway are financed by the country’s national budget. Norway has one of the highest per capita GDPs globally, and as a result, the country’s per capita health expenditure is significantly higher compared to most countries, with over USD 9020.63 per capita in 2021.
Moreover, public sources play a significant role, accounting for 85.5% of the current health expenditure, making it the highest share among European countries. In addition, the growing number of government initiatives to enhance healthcare in the country is expected to drive market growth.
Reasons to subscribe to Norway drug device combination products market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway drug device combination products market databook
-
Our clientele includes a mix of drug device combination products market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into Norway drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway drug device combination products market size, by product, 2018-2030 (US$M)
Norway Drug Device Combination Products Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
